Quick Answer
Tonix Pharmaceuticals Holding Corp. reported Shares Outstanding of 12.79 million shares for fiscal year 2025.
Tonix Pharmaceuticals Holding Corp. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 12.79M | -97.7% |
| 2025 | 559.04M | +12646.3% |
| 2024 | 4.39M | -95.4% |
| 2024 | 95.54M | +456479.4% |
| 2023 | 20,926 | -99.8% |
| 2022 | 12.37M | -20.9% |
| 2021 | 15.64M | -92.4% |
| 2020 | 206.01M | +2314.7% |
| 2019 | 8.53M | -45.7% |
| 2019 | 15.72M | +4681.8% |
| 2018 | 328,689 | -78.5% |
| 2018 | 1.53M | -80.5% |
| 2017 | 7.83M | +99.8% |
| 2016 | 3.92M | +108.1% |
| 2015 | 1.88M | -82.6% |
| 2014 | 10.81M | +85.6% |
| 2013 | 5.82M | +169.7% |
| 2012 | 2.16M | -92.0% |
| 2011 | 27.07M | +50.1% |
| 2010 | 18.03M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 10.17M | -93.5% | +34.7% |
| June 30, 2025 | 7.55M | -23.3% | +9.7% |
| March 31, 2025 | 6.88M | -90.7% | -98.8% |
| January 31, 2025 | 559.04M | — | +12646.3% |
| December 31, 2024 | 4.39M | +111.2% | -97.2% |
| September 30, 2024 | 155.63M | +776.2% | +1482.8% |
| June 30, 2024 | 9.83M | -8.6% | -89.7% |
| May 31, 2024 | 95.54M | — | +29.6% |
- Tonix Pharmaceuticals Holding Corp. showed a decrease of -97.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Tonix Pharmaceuticals Holding Corp.’s shares outstanding has declined by 29.1% (from 18.03 million shares to 12.79 million shares).
- The most recent figure is from Tonix Pharmaceuticals Holding Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: